���ϴ��¼�

Alpha Technology, LLC (Alpha Tech), owned and operated by Department Head and Professor Dr. Jack Skinner, has sought to commercialize technologies invented at ���ϴ��¼� since 2018. Following BOR policy 407 approval in 2018, Alpha Tech licensed an antiviral additive discovered at ���ϴ��¼� by Skinner and Research Associate and University of Montana alum Dr. Jessica Andriolo. Through several granted pre-clinical contracts, the antiviral is now classified as “highly active” against three strains of virus, and “moderately active” against a fourth. Alpha Tech has also licensed an on-demand wound care technology developed at ���ϴ��¼� that enables safe delivery of drug-activated fiber bandages deposited directly onto wound sites. Alpha Tech partners with ���ϴ��¼� through a Facilities Use Agreement, and co-development of several STTR proposals. Alpha Tech has been granted several economic development grants by the Butte-Silver Bow City Council, and has signed a letter of intent with the Praxis Center, a state-of-the-art rural medicine training facility in uptown Butte. Alpha Tech will exist in a business incubator within the Praxis Center, facilitating the relationship between ���ϴ��¼� and the Praxis Center, as well as connecting the MUS to small businesses built on MUS-invented technologies.